IFN a-polymer complex

Drug Profile

IFN a-polymer complex

Alternative Names: polyActive™- IFN-a; sustained release IFN-a

Latest Information Update: 14 May 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OctoPlus
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Interferon alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 14 May 2008 Discontinued - Phase-I for Cancer in Netherlands (unspecified route)
  • 29 Oct 2007 IsoTis OrthoBiologics has been acquired by Integra LifeSciences
  • 01 May 2007 OctoPlus acquires full rights to the PolyActive™ technology from IsoTis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top